Dr. Efstathiou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6445 Main Street
OPC 24
Houston, TX 77030Phone+1 713-441-9948Fax+1 713-441-8791- Is this information wrong?
Education & Training
- University of AthensClass of 1998
Certifications & Licensure
- TX State Medical License 2019 - 2023
- OK State Medical License 2020 - 2021
Clinical Trials
- Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer Start of enrollment: 2015 Oct 29
- Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer Start of enrollment: 2017 Oct 13
- Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2018 Mar 06
- Join now to see all
Publications & Presentations
PubMed
- Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer.Emanuela Gentile, Andrew W Hahn, Jian H Song, Anh Hoang, Peter D A Shepherd, Sumankalai Ramachandran, Nora M Navone, Eleni Efstathiou, Mark Titus, Sue-Hwa Lin, Christo...> ;Cancer Research Communications. 2023 Dec 13
- Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?Maha Hussain, Cora N Sternberg, Eleni Efstathiou, Karim Fizazi, Qi Shen, Xun Lin, Jennifer Sugg, Joyce Steinberg, Bettina Noerby, Ugo De Giorgi, Neal D Shore, Fred Saad> ;Future Oncology. 2023 Sep 1
- 3 citationsThe biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.Neeraj Agarwal, Tian Zhang, Eleni Efstathiou, Nicolas Sayegh, Arne Engelsberg, Fred Saad, Karim Fizazi> ;European Journal of Cancer. 2023 Oct 1
- Join now to see all
Press Mentions
- Niraparib and Abiraterone Combination Is Beneficial in Prostate CancerMarch 20th, 2023
- Latest in Hormone Sensitive Prostate CancerFebruary 18th, 2023
- Niraparib Improves rPFS in BRCA-Mutated Metastatic Castration-Resistant Prostate CancerFebruary 17th, 2023
- Join now to see all
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
- Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: